— Know what they know.
Not Investment Advice

ICVX NASDAQ

Icosavax, Inc.
1W: +0.0% 1M: +0.1% 3M: +47.5% 1Y: +87.2%
$15.31
Last traded 2024-02-29 — delisted
NASDAQ · Healthcare · Biotechnology · $769.0M mcap · 29M float · 4.23% daily turnover

Cash Flow Trends

Operating Cash Flow
-$62M -60.0% ▼
Capital Expenditures
$11M -1004.7% ▼
Free Cash Flow
-$73M -84.1% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$221M -183.3% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2019FY2020FY2021FY2022
— Operating Activities —
Net Income-$5M-$19M-$67M-$92M
Depreciation & Amort.$0$1K$82K$860K
Stock-Based Comp.$72K$257K$29M$22M
Change in Working Capital$656K$4M-$2M$8M
Other Non-Cash Items$0$417K$264K-$545K
Operating Cash Flow-$5M-$14M-$39M-$62M
— Investing Activities —
Capital Expenditures$0-$11K-$1M-$11M
Acquisitions (Net)$0$0$0$158M
Investment Purchases$0$0$0-$221M
Investment Sales$0$0$0$63M
Other Investing$0$0$0-$158M
Investing Cash Flow$0-$11K-$1M-$169M
— Financing Activities —
Net Debt Issuance$0$0$0$0
Stock Repurchased$0$0$0$0
Dividends Paid$0$0$0$0
Other Financing$27M$7M$305M$10M
Financing Cash Flow$27M$7M$305M$10M
Net Change in Cash$22M-$8M$265M-$221M
Cash End of Period$23M$15M$281M$60M
Free Cash Flow-$5M-$14M-$40M-$73M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms